Reflections on Medicine and Life by Dr. S.P. Kalantri
On 18 June 2020, Dr. C. S. Pramesh, the Director of the Tata Memorial Hospital texted me a message and then called me asking if I would be willing to do a talk on Covid and research during Pandemic. A day after. Although I had little time to prepare, I didn’t blink an eyelid to … Read the essay
WHO had resumed trials of the drug hydroxychloroquine as a part of the Solidarity Trial to find a cure for the novel coronavirus, COVID-19. The trial had been stopped because a study published in The Lancet said the drug wasn’t as effective as touted. This study is now under the scanner after investigation by the … Read the essay
How are COVID-19 vaccines being developed? Several drugmakers have announced that they are moving to Phase 2 of COVID-19 vaccine clinical trials; the Oxford vaccine by Serum Institute of India backed by Adar Poonawala has started Phase 3 clinical trials. What do these phases mean? Should we think that we are close to a getting … Read the essay
No other drug, at least in the early phase of Covid pandemic, evoked as much interest, publicity, blind and demand as Hydroxychloroquine did. It took a couple of well -designed randomized controlled trials to indicate that the drug does not work, and is associated with serious adverse events when used to prevent or treat Covid. … Read the essay
Hydroxychloroquine (HCQ) has been the biggest buzzword across the world lately. Until December 2019, this was a meek drug, used mainly by rheumatologists, internists, and dermatologists for inflammatory diseases. Its cousin Chloroquine has been the most popular drug for malaria. We have known and used these drugs for decades. The antiviral properties of these drugs … Read the essay